These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oral antidiabetic drug use in the elderly. Bressler R; Johnson DG Drugs Aging; 1996 Dec; 9(6):418-37. PubMed ID: 8972242 [TBL] [Abstract][Full Text] [Related]
4. Incidence of potential drug-drug interactions with antidiabetic drugs. Samardzic I; Bacic-Vrca V Pharmazie; 2015 Jun; 70(6):410-5. PubMed ID: 26189304 [TBL] [Abstract][Full Text] [Related]
5. [Risk and benefit of sulfonylureas--their role in view of new treatment options for type 2 diabetes]. Rustenbeck I Med Monatsschr Pharm; 2016 Feb; 39(2):65-72; quiz 73-4. PubMed ID: 26983335 [TBL] [Abstract][Full Text] [Related]
6. [Focusing on elderly patients and concomitant drug therapy - Diabetology for the general practitioner]. Urban & Vogel MMW Fortschr Med; 2015 Apr; 157(8):38. PubMed ID: 26012680 [No Abstract] [Full Text] [Related]
7. Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy. Parks M; Rosebraugh C N Engl J Med; 2010 Mar; 362(9):774-7. PubMed ID: 20164475 [No Abstract] [Full Text] [Related]
8. Cardiovascular effects of some antidiabetic drugs. Med Lett Drugs Ther; 2017 Aug; 59(1527):136-138. PubMed ID: 28787745 [No Abstract] [Full Text] [Related]
9. Liraglutide (Victoza) for type 2 diabetes. Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660 [TBL] [Abstract][Full Text] [Related]
10. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities. Malesker MA Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965 [TBL] [Abstract][Full Text] [Related]
11. New diabetes drugs: which one is right for you? Johns Hopkins Med Lett Health After 50; 1999 Jan; 10(11):4-5. PubMed ID: 9889730 [No Abstract] [Full Text] [Related]
12. Oral hypoglycemic agents in the management of non-insulin-dependent diabetes mellitus among the elderly. McAvoy KH Diabetes Educ; 1991; 17(5):411-3. PubMed ID: 1879284 [TBL] [Abstract][Full Text] [Related]
13. [Clinically important effects of oral antidiabetic drug interactions]. Drzewoski J; Kopff B Pol Merkur Lekarski; 2000 Sep; 9(51):605-7. PubMed ID: 11126985 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone and rosiglitazone for diabetes. Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802 [TBL] [Abstract][Full Text] [Related]
18. Troglitazone: a review of its use in the management of type 2 diabetes mellitus. Plosker GL; Faulds D Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691 [TBL] [Abstract][Full Text] [Related]
19. New therapies for the management of type 2 diabetes. Barnett A Nurs Times; 2001 Feb 8-14; 97(6):34-6. PubMed ID: 11954247 [No Abstract] [Full Text] [Related]
20. Reducing drug usage and adverse effects. Part I: Diabetes management. Baron M Health Care Food Nutr Focus; 2005 Apr; 22(4):1, 3-7. PubMed ID: 15856659 [No Abstract] [Full Text] [Related] [Next] [New Search]